Clinical trial
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in…
NCT00432757 · Vistakon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00432757 |
|---|---|
| Title | Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis |
| Official title | A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers |
| Lead sponsor | Vistakon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Ketotifen with a Contact Lens (generic name not yet established) |
| Enrollment | 120 |
| Start date | Jan 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Apr 9, 2009 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: